Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603456'
s Days Payable Range Over the Past 10 Years
Min: 79.76 Med: 105.06 Max: 141.86
Current: 119.8
During the past 13 years, Zhejiang Jiuzhou Pharmaceutical Co's highest Days Payable was 141.86. The lowest was 79.76. And the median was 105.06.
SHSE:603456's Days Payable is ranked better than 65.26% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.16
vs SHSE:603456: 119.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Jiuzhou Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Jiuzhou Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Jiuzhou Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhejiang Jiuzhou Pharmaceutical Co's Days Payable falls into.
Zhejiang Jiuzhou Pharmaceutical Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) has a Days Payable of 107.97 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. This is near median its historical median of 105.06. Over the past decade, Zhejiang Jiuzhou Pharmaceutical Co's Days Payable has ranged from 79.76 to 141.86. According to the industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #322 out of 927 companies in the Drug Manufacturers industry, placing it in the top 34.7%.
Is Zhejiang Jiuzhou Pharmaceutical Co's Days Payable too high?
Zhejiang Jiuzhou Pharmaceutical Co's current Days Payable of 107.97 is near median its 10-year median of 105.06. Over the past 10 years, this metric has ranged from a low of 79.76 to a high of 141.86. The Drug Manufacturers industry median Days Payable is 90.16. Zhejiang Jiuzhou Pharmaceutical Co's value of 107.97 is 19.8% above this industry median. Based on the distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #322 out of 927 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zhejiang Jiuzhou Pharmaceutical Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Jiuzhou Pharmaceutical Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Jiuzhou Pharmaceutical Co ranks #322 out of 927 companies for Days Payable. This puts Zhejiang Jiuzhou Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 90.16. Zhejiang Jiuzhou Pharmaceutical Co's value of 107.97 is 19.8% above this benchmark. Historically, Zhejiang Jiuzhou Pharmaceutical Co's own Days Payable has ranged from 79.76 to 141.86 over the past decade. While the company's 10-year median is 105.06 vs. the industry median of 90.16, Zhejiang Jiuzhou Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.16, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Jiuzhou Pharmaceutical Co's current Days Payable of 107.97 is 19.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhejiang Jiuzhou Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Jiuzhou Pharmaceutical Co's current Days Payable is 107.97, which is near median its own 10-year median of 105.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Jiuzhou Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.96, compared to a current price of ¥15.46 — trading 8.8% below its estimated fair value. The current Days Payable is 107.97, which is near median its 10-year median of 105.06 and 19.8% above the Drug Manufacturers industry median of 90.16. Zhejiang Jiuzhou Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456), the current Days Payable is 107.97 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Jiuzhou Pharmaceutical Co (SHSE:603456) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Jiuzhou Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥15.46 is trading 8.8% below its estimated GF Value™ of ¥16.96.
GuruFocus considers Zhejiang Jiuzhou Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:603456:
Days Payable: 107.97 (near median its 10-year median of 105.06)
GF Value™: ¥16.96 vs. price of ¥15.46 (8.8% below fair value)
Industry Position: 19.8% above the Drug Manufacturers median (#322 of 927)
No single metric tells the full story. See the SHSE:603456 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based pharmaceutical manufacturer. The company is primarily engaged in the manufacturing, research, development, and sale of active pharmaceutical ingredients, intermediates, asymmetric catalyst, and lithium battery materials. Its active pharmaceutical ingredient offerings include Carbamazepine, Duloxetine, Bezafibrate, Meropenem, Sulphadimethoxine Sodium, Oxcarbazepine, and Amprolium, among others. The firm also provides services of new drug contract development and manufacturing organization to the international pharmaceutical giant.
95GF Score
Get the complete analysis for SHSE:603456
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603456 has been successfully added to your 
